Champions Oncology, INC. (CSBR) — 10-K Filings
All 10-K filings from Champions Oncology, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Champions Oncology's Losses Widen to $10.9M Amid Revenue Growth
— Jul 23, 2025 Risk: high
CHAMPIONS ONCOLOGY, INC. reported a net loss of $10.9 million for the fiscal year ended April 30, 2025, a significant increase from the $7.8 million net loss in -
Champions Oncology Files 2024 10-K
— Jul 19, 2024 Risk: low
Champions Oncology, Inc. filed its 10-K for the fiscal year ending April 30, 2024. The company, previously known as Champions Biotechnology, Inc., is involved i
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX